Related by context. All words. (Click for frequent words.) 70 Metastases 70 Carcinoma 69 Recurrences 69 Radical Prostatectomy 68 Disease Progression 68 Asymptomatic 67 Carcinomas 67 Breast Cancers 67 Breast Cancer Recurrence 67 Cardiovascular Events 67 Improves Outcomes 66 Venous Thromboembolism 66 Metastatic 66 Coronary Artery 66 leiomyomas 66 Radiofrequency Ablation 66 Contralateral 65 Proteinuria 65 Adjuvant Therapy 65 Improves Survival 65 Metastatic Prostate Cancer 65 Appears Safe 65 Thromboembolism 65 Unresectable 65 Renal Cell Carcinoma 65 Adjuvant Chemotherapy 65 Adenomas 65 Prostatic 65 Restenosis 64 Peritonitis 64 Patients Undergoing 64 Patients Receiving 64 NMIBC 64 Squamous Cell Carcinoma 64 Neoadjuvant 64 Localized Prostate Cancer 64 Postoperative 64 Treating Chronic 64 Breast Cancer Patients 64 Thrombocytopenia 64 B Cell Lymphoma 64 Prostatectomy 64 Adjuvant Treatment 63 Ischemic 63 Tumor Growth 63 Adenoma 63 Preterm Delivery 63 Knee Osteoarthritis 63 pT2 63 Bone Mineral Density 63 Unfractionated Heparin 63 Precancerous 63 Adenocarcinoma 63 Leukemias 63 Endometrial Cancer 63 Liver Failure 63 Septic Shock 63 Relapsing Remitting Multiple Sclerosis 63 Thrombotic 63 Immunosuppression 63 pulmonary metastases 63 Elderly Patients 63 Malignancies 63 Prostate Cancer Progression 63 Thromboembolic 63 urothelial carcinoma 62 endometrial carcinoma 62 Aggressive Prostate Cancer 62 Malignant Melanoma 62 Papillary 62 Follicular Lymphoma 62 Partial Response 62 Kidney Function 62 Lymph Nodes 62 Gene Mutation 62 Hypotension 62 Chronic Hepatitis C 62 CT Angiography 62 Catheter Associated 62 node metastases 62 Improved Survival 62 Antitumor Activity 62 Hormone Receptor Positive 62 Prostate Cancer Recurrence 62 Viral Suppression 62 Left Ventricular Hypertrophy 62 Prognostic Value 62 Survival Benefit 62 Fracture Risk 62 Idiopathic 62 CIN3 62 Stomach Cancer 62 Patients Treated 62 Atypical Hemolytic Uremic Syndrome 62 Stent Implantation 62 Hemolysis 62 Immune Responses 62 Advanced Prostate Cancer 62 Postmenopausal Women 62 Proves Effective 62 Toxicities 62 Pediatric Patients 62 Hormone Refractory Prostate Cancer 61 Cancer Recurrence 61 Anthracycline 61 Microalbuminuria 61 Invasive Breast Cancer 61 Glioma 61 Metastatic Renal Cell Carcinoma 61 PSADT 61 Heart Failure Patients 61 Statin Therapy 61 Non Alcoholic Fatty 61 Ischemic Stroke 61 Myocardial Ischemia 61 Ultrasonography 61 Lipid Levels 61 Infected Patients 61 Kidney Failure 61 biochemical recurrence 61 Esophageal 61 Urinary Tract Infections 61 severe neutropenia 61 Subtypes 61 Statistically Significant 61 Mitral Regurgitation 61 Improve Survival 61 Pooled Analysis 61 Drug Prevents 61 Node Positive 61 Duodenal 61 Carotid Stenting 61 Colorectal Adenomas 61 Castration Resistant Prostate Cancer 61 Skin Cancers 61 Neoadjuvant Chemotherapy 61 Esophageal Cancer 61 Endometrial 61 paragangliomas 61 Prostate Cancer Risk 61 Orthostatic Hypotension 61 Radioimmunotherapy 61 SLNB 61 Basal Cell 61 Skin Lesions 61 Blood Clots 61 Rheumatoid Arthritis Patients 61 Autologous Stem Cell Transplantation 61 Abnormality 61 metastatic malignant 61 biochemical relapse 61 Myelofibrosis 61 Depressive Symptoms 61 Patients Suffering 61 Clinical Outcome 61 Androgen Deprivation Therapy 61 Arrhythmogenic 61 Survival Rates 61 Neoplasms 61 Incidence 61 Hemodialysis Patients 61 Viral Load 61 artery stenosis 61 Fibrosis 61 locoregional recurrence 61 Organ Rejection 61 Subgroup Analysis 61 Pulmonary Artery 61 Delayed Graft Function 60 Placebo Controlled Trial 60 Appendicitis 60 Slow Progression 60 Advanced Melanoma 60 Lesion 60 distant metastasis 60 Lowers Risk 60 Tonsillectomy 60 Monotherapy 60 Bone Metastases 60 Chronic Pelvic Pain 60 Gene Linked 60 Liver Metastases 60 Cancer Diagnosis 60 Neutropenia 60 Mortality Risk 60 colorectal adenoma 60 Comorbidities 60 Urinary 60 Colorectal Cancer Patients 60 Cystectomy 60 Left Ventricular 60 Prognostic Significance 60 Renal Artery 60 Lung Cancer Patients 60 specific antigen PSA 60 Previously Untreated 60 Obese Patients 60 Node Negative 60 radical prostatectomy RP 60 Arrhythmias 60 Genes Linked 60 Lymph Node 60 Cholesterol Levels 60 Cognitive Impairment 60 Prostate Cancer Surgery 60 Viral Infection 60 Breast Tumors 60 Gene Variant 60 Overactive Bladder 60 Breast Cancer Treatment 60 Thyroid Cancer 60 Minimally Invasive Treatment 60 cerebral vasospasm 60 Oral Fingolimod 60 Metastatic Disease 60 perioperative complications 60 Intracerebral Hemorrhage 60 Relapsing Multiple Sclerosis 60 Cell Lymphoma 60 esophageal carcinoma 60 operable breast cancer 60 Effective Treatments 60 Combination Treatment 60 Newly Diagnosed Multiple Myeloma 60 Ovarian Cancer Patients 60 Bladder Cancer 60 Patients Treated With 60 Cervical Disease 60 Cognitive Decline 60 carcinoid tumor 60 Increased Mortality 60 baseline LDH 60 Metastatic Colorectal Cancer 60 Graft Versus Host 60 Prostate Cancer Diagnosis 60 Cardiovascular Outcomes 60 Blood Clot Risk 60 Increases Risk 60 Preterm Infants 60 Infarction 60 Exacerbations 60 Acute Coronary 60 pelvic lymphadenectomy 60 Predict Breast Cancer 60 ischemic lesions 60 Ileus 60 pancytopenia 60 Refractory Hodgkin Lymphoma 60 Myelodysplastic Syndrome 60 Vertebral Compression Fractures 60 Stenosis 60 Drug Combo 60 Subarachnoid Hemorrhage 60 Chemoradiation 59 cervical lymph nodes 59 Gene Mutations 59 HER2 Positive Breast Cancer 59 precursor lesions 59 Soft Tissue Sarcoma 59 Prognostic Factors 59 Breast Density 59 adrenalectomy 59 Rectal Cancer 59 Premenopausal Women 59 Stroke Risk 59 STRIDE PD 59 Genes Predict 59 Ejection Fraction 59 Ovarian Cancers 59 Cardiovascular Mortality 59 Nodules 59 Radiation Dose 59 breast carcinoma 59 adenomatous polyps 59 Intracranial 59 Prolongs Survival 59 Systolic Blood Pressure 59 cytoreductive surgery 59 hemorrhagic complications 59 Chronic Sinusitis 59 Hypertensive Patients 59 Bloodstream Infections 59 Cognitive Function 59 Dual Antiplatelet Therapy 59 Relapsed Refractory 59 Genes Associated 59 Shows Promise Against 59 Postmenopausal 59 Gastric Cancer 59 Vulvar 59 Meta Analysis 59 Respiratory Symptoms 59 Malignancy 59 Increased Risk 59 Prostate Cancer Patients 59 HER2 expression 59 Pulmonary Embolism 59 complement inhibitor eculizumab 59 Atrial 59 Fluorouracil 59 Lung Cancer Trial 59 Aneurysm Repair 59 Main Outcome Measure 59 Postherpetic Neuralgia 59 Virus Infection 59 Predictive Value 59 Malignant 59 Tumor Cells 59 Non Alcoholic Steatohepatitis 59 dysuria 59 malignant neoplasm 59 polyposis 59 Coronary Artery Bypass Surgery 59 Resection 59 Intracerebral 59 Chronic Myeloid Leukemia 59 Long Term Outcomes 59 Stomatitis 59 neoadjuvant treatment 59 intravascular hemolysis 59 Chronic Renal Failure 59 cholecystitis 59 gastroduodenal 59 lichen planus 59 Surgical Procedures 59 Randomized Trials 59 Small Intestine 59 Prostate Biopsy 59 Critically Ill Patients 59 postoperative mortality 59 Colorectal Cancers 59 Breast Carcinoma 59 Predict Response 59 GISTs 59 hypophosphatemia 59 Cardiovascular Disease Risk 59 Antiplatelet Therapy 59 Panic Disorder 59 Myocardial Infarction 59 Non Responders 59 Unstable Angina 59 Axillary 59 Hepatocellular Carcinoma 59 Gliomas 59 Glioblastoma Multiforme 59 Treatment Naive HIV 59 Anti Tumor Activity 59 thymoma 59 Brain Metastases 59 Prophylactic Treatment 59 Mouse Model 59 neoplasias 59 Acute Myocardial Infarction 59 neutropenia dehydration dyspnea 59 cytopenias 59 nonmetastatic 59 F FDG PET 59 Obesity Linked 59 Nonspecific 59 Breast Tissue 59 Gum Disease 59 Exacerbation 59 Radiation Doses 59 ST Segment Elevation 59 HER2 Positive 59 tumor recurrence 59 mammographic density 59 Well Tolerated 59 Hip Fractures 59 atypical ductal hyperplasia 58 Disease Severity 58 thrombocytosis 58 leucopenia 58 Total Knee Arthroplasty 58 Sonographic 58 endoscopic ultrasonography 58 Potentially Fatal 58 Patency 58 PCa 58 Complication Rates 58 Effectively Treats 58 thyroglobulin 58 Stent thrombosis 58 Liver Injury 58 Breast Cancer Risk 58 cholestasis 58 pericardial effusion 58 monoclonal gammopathy 58 Antibiotic Use 58 Bacterial Infections 58 gastric adenocarcinoma 58 Test Detects 58 Dysplasia 58 pulmonary metastasis 58 ADPKD 58 mucinous 58 Previously Treated 58 Cutaneous T 58 Complication 58 Hemoglobin Levels 58 Smoking Linked 58 Treatment Reduces 58 thyroiditis 58 Long Term Survival 58 Risk Stratification 58 pT3 58 Allogeneic 58 Colorectal Cancer Risk 58 Chronic Heart Failure 58 Relapses 58 Ventricular 58 stage IIIB 58 choriocarcinoma 58 Myelodysplastic Syndromes 58 Randomized Study 58 adjuvant radiotherapy 58 nodal metastases 58 Phase III Pivotal Trial 58 Predict Risk 58 Chronic Bronchitis 58 Cervical Dysplasia 58 Diffuse Large B 58 Pancreatic 58 gadolinium enhanced 58 Lesions 58 Ascites 58 bullous 58 rebleeding 58 severe oral mucositis 58 Legg Calvé Perthes disease 58 grade squamous intraepithelial 58 Testicular 58 neoplasia PIN 58 Ischaemic 58 Treatment Shows Promise 58 Iron Deficiency 58 Demonstrates Efficacy 58 Acute Ischemic Stroke 58 Angiographic 58 leukoencephalopathy 58 Bone Fractures 58 Hormone Therapy 58 Skeletal Muscle 58 Reduced Risk 58 Hormone Levels 58 Coronary Angiography 58 Inflammatory Markers 58 papillary thyroid carcinoma 58 invasive aspergillosis 58 Angioedema 58 Who Underwent 58 lymph node metastasis 58 Advanced Renal Cell 58 advanced adenoma 58 Comorbid 58 Ventricular Tachycardia 58 Controlled Trial 58 Adiposity 58 perioperative morbidity 58 pathologic diagnosis 58 Glycemic Control 58 Myeloma Patients 58 Diabetic Patients 58 Ureteral 58 subtrochanteric 58 Lung Cancer Survival 58 ipsilateral stroke 58 variceal bleeding 58 Drug Shows Promise 58 Lymphomas 58 Bypass Surgery 58 Sclerosis 58 histological subtype 58 Polyps 58 Transplant Patients 58 postoperative complication 58 Tolerability 58 Stent Restenosis 58 Acute myeloid leukemia 58 bladder carcinoma 58 Premature Infants 58 gastric carcinoma 58 parathyroid carcinoma 58 Hurthle cell 58 Resistant Hypertension 58 Brain Tumors 58 Lymphocytic 58 Radiation Induced 58 Multicenter Trial 58 virologic response 58 Mortality 58 Antibiotic Treatment 58 hematologic toxicity 58 angiographically 58 seminomas 58 Preoperative 58 lymphadenopathy 58 Cardiac Resynchronization 58 Subtype 58 curative resection 58 Childhood Leukemia 58 Venous thromboembolism 58 Infarct 58 pCR 58 Advanced Ovarian Cancer 58 Surgical Treatment 58 Treatable 58 pheochromocytoma 58 Anal Cancer 58 Retinopathy 58 Inactivation 58 Patellofemoral 58 Uterine 58 Migraine Headaches 58 virological response 58 lymph node enlargement 58 Pneumococcal Vaccine 58 Etiology 58 prognostic indicator 57 Iron Overload 57 hematological parameters 57 transplantation HCT 57 Genital Herpes 57 Dialysis Patients 57 osteosarcomas 57 Predict Prostate Cancer 57 Acute Coronary Syndromes 57 Coronary Artery Bypass Graft 57 Short Stature 57 Antibiotic Resistant 57 Brain Aneurysms 57 Progressive Multifocal Leukoencephalopathy 57 Sentinel Lymph Node Biopsy 57 Therapy Shows Promise 57 HER2 overexpression 57 paraganglioma 57 Non Melanoma Skin 57 Catheter Ablation 57 Renal Function 57 Contrast Agents 57 Retreatment 57 LDL Cholesterol 57 Testosterone Levels 57 pretest probability 57 Naive Patients 57 Solid Tumors 57 Pre Cancerous 57 Histological 57 neurologic deficits 57 Inhaled Corticosteroids 57 Endothelial Function 57 Capsular 57 Genetic Mutations 57 Artery Disease 57 Plus Ribavirin 57 grade cervical intraepithelial 57 underwent resection 57 liver metastasis 57 Cardiotoxicity 57 preoperative diagnosis 57 radiotherapy RT 57 bone metastasis 57 Hypertrophic 57 Prostate Surgery 57 Dilated Cardiomyopathy 57 Experimental Vaccine 57 Is Well Tolerated 57 Hypertrophy 57 adenomatous 57 Elevated Levels 57 locoregional 57 Hysterectomy 57 Physical Function 57 Phase 2b Clinical Trial 57 carotid stenosis 57 Cholangiocarcinoma 57 del 5q 57 Heterogeneity 57 Malignant Glioma 57 radioiodine therapy 57 Basal Cell Carcinoma 57 estimated glomerular filtration 57 Placebo Controlled Study 57 perioperatively 57 Neuroendocrine Tumors 57 progression TTP 57 Stent Thrombosis 57 Neuroprotective Effects 57 Hyperlipidemia 57 Chronic Insomnia 57 Stenting 57 Vitamin D Linked 57 HBeAg 57 Venous Thrombosis 57 tumor lysis syndrome 57 LVNC 57 Bulimia Nervosa 57 Relapsed 57 Sentinel node biopsy 57 BRCA2 mutation carriers 57 lymphadenectomy 57 thyrotoxicosis 57 histologically proven 57 Postprandial 57 Intracoronary 57 Unstable angina 57 Chronic Prostatitis 57 Endothelial Cells 57 Shows Promising 57 Main Outcome Measures 57 cystectomy 57 FDG-PET/CT 57 Ductal Carcinoma 57 Endothelial 57 Stress Incontinence 57 thromboembolic 57 Osteoporosis Drugs 57 Genetic Variations 57 Stress Induced 57 thyroid nodules 57 Therapy Reduces 57 SCr 57 Ovarian Cancer Risk 57 Biopsies 57 antiphospholipid syndrome 57 MR Angiography 57 Genetic Variants 57 Related Mortality 57 parathyroidectomy 57 Metastatic Melanoma 57 Nilotinib 57 postoperative morbidity 57 Liver Tumors 57 Thrombus 57 occlusive disease 57 Severe Asthma 57 Dementia Risk 57 Subclinical 57 Cardiogenic Shock 57 Epstein Barr Virus 57 Anterior Cruciate Ligament Reconstruction 57 MRSA Infections 57 Pregnancy Complication 57 Malformations 57 renal cell carcinomas 57 Circulating Tumor Cells 57 Shows Efficacy 57 Psychiatric Disorders 57 neoadjuvant therapy 57 Reduces Mortality 57 Cerebrospinal Fluid 57 Inhibits 57 Combo Therapy 57 Survival Rate 57 Pegylated Liposomal Doxorubicin 57 Prospective Cohort Study 57 Carotid Endarterectomy 57 spontaneous bacterial peritonitis 57 ASCUS 57 neoplasms 57 Atherosclerotic 57 Sonography 57 spinal cord compression 57 Tumor Cell 57 Stem Cell Treatment 57 Rheumatoid 57 Abdominal Pain 57 Genetic Mutation 57 Often Misdiagnosed 57 Prolonged Survival 57 Hepatotoxicity 57 recurrent glioblastoma multiforme 57 Chemotherapy induced 57 atrioventricular block 57 Adefovir 57 Brain Atrophy 57 Idiopathic Thrombocytopenic Purpura ITP 57 Chronic HCV 57 Randomized Controlled Trial 57 Testicular Cancer 57 Regurgitation 57 pleural effusion 57 radiographic progression 57 Randomized Controlled Trials 57 Asthma Attacks 57 Squamous 57 Intracranial Aneurysms 57 Adjuvant therapy 57 Coronary Arteries 57 Migraine Pain 57 androgen deprivation 57 metachronous 57 Gastric Ulcers 57 cytomegalovirus infection 57 Rare Genetic 57 cytoreduction 57 Drug Resistant 57 Kidney Transplant Recipients 57 tonsillar 57 Lung Cancers 57 Peritoneal 57 Multiple Myeloma Patients 57 Cutaneous 57 Nonalcoholic Fatty Liver Disease 57 cTnI 57 Relapsed Multiple Myeloma 57 Suicidal Ideation 57 liver transplant recipients 57 Less Invasive 57 Prostate Cancer Treatment 57 Ischemic Heart Disease 57 Antidepressants Linked 57 Myeloid 57 Radiofrequency Ablation RFA 57 VUR 57 Uterine Fibroid Embolization 57 Treatment Naive Patients 57 Lung Function 57 histologic subtype 57 Interferon Beta 57 colorectal carcinoma 57 Pathologic 57 Progenitor Cells 57 Breast Cancer Metastasis 57 Cystic 57 endometrial hyperplasia 57 Bivalirudin 57 CIN2 + 57 Gestational Diabetes 56 PAOD 56 fallopian tube carcinoma 56 proctitis 56 Thrombolysis 56 atrophic gastritis 56 enterocolitis 56 Polycystic Ovary Syndrome 56 Suicidality 56 Insulin Sensitivity 56 prostate cancer CaP 56 Benign Prostatic Hyperplasia 56 Hemangiomas 56 Kidney Transplant Patients 56 liver resection 56 Sexual Function 56 anterior uveitis 56 Electrical Stimulation 56 Acute Renal Failure 56 Urinary Incontinence 56 ORLive Presents 56 Hyperplasia 56 Life Threatening 56 Wilms tumors 56 deep venous thromboses 56 giant cell arteritis 56 Recurrent Stroke 56 Capecitabine 56 Help Predict 56 neurologic complications 56 Necrosis 56 Heart Attacks 56 lactate dehydrogenase LDH 56 neoplasm 56 SUVmax 56 Metastatic Breast Cancer 56 HNSCC 56 Myocardial infarction 56 hemodilution 56 empyema 56 Gene Variants 56 thyroid carcinoma 56 Levels Linked 56 adnexal mass 56 LV dysfunction 56 cholelithiasis 56 Limb Ischemia 56 Brugada syndrome 56 Aortic 56 Bacteremia 56 orchitis 56 cutaneous melanoma 56 undergoing radical prostatectomy 56 androgen suppression 56 recurrence 56 Squamous Cell 56 endometrial cancers 56 Total Hip Arthroplasty 56 hepatitis B reactivation 56 Disease GVHD 56 epithelial ovarian 56 Symptom Relief 56 Pregnancy Linked 56 lung carcinomas 56 Oral Cavity 56 histologically confirmed 56 Meets Primary Endpoint 56 Hemorrhagic 56 grade glioma 56 Fungal Infections 56 gastro esophageal reflux 56 neoadjuvant 56 Clinical Trial Results 56 Bacterial Infection 56 thrombotic complications 56 Transplant Rejection 56 Gallbladder 56 pneumonectomy 56 Mitomycin C 56 mediastinal 56 Lung Cancer Risk 56 peritoneal cancer 56 Low Dose 56 ultrasonographic 56 epithelial tumors 56 Novel Inhibitor 56 anaplastic 56 Embolization 56 Statin Drugs 56 Clinical Trial Data 56 lupus erythematosus 56 Percutaneous Coronary Intervention 56 HBeAg negative 56 Slows Progression 56 Systematic Review 56 Enlarged Prostate 56 perioperative mortality 56 Demonstrates Positive 56 appendiceal 56 coinfection 56 allograft rejection 56 chemoradiation therapy 56 Carotid Artery 56 haematologic 56 Adverse Effects 56 Epileptic Seizures 56 Calcification 56 transitional cell carcinoma 56 differentiated thyroid 56 relapsed Acute Myeloid 56 Functional Outcomes 56 TP# mutations 56 Polymorphisms 56 Vaccine Shows Promise 56 Corneal Transplant 56 urolithiasis 56 Blocked Arteries 56 Endovascular Treatment 56 Osteoporosis Treatment 56 demyelinating 56 histopathologic diagnosis 56 Drug Resistant TB 56 duplex ultrasonography 56 #.#ng/ml 56 Proliferative 56 Genotypes 56 diagnosing coronary artery 56 Respiratory Distress 56 chemoradiotherapy 56 Helicobacter pylori infection 56 Robotic Assisted 56 Zollinger Ellison syndrome 56 clinicopathological features 56 Febrile 56 Kidney Stones 56 Hematologic 56 Colon Polyps 56 urothelial cancer 56 Vasculitis 56 Prostate Cancer Screening 56 Parathyroid 56 calculi 56 transabdominal 56 Diabetic Foot Ulcers 56 precancerous condition 56 Acute Myelogenous Leukemia 56 malperfusion 56 Sirolimus Eluting Stent 56 Potent Anti 56 Curable 56 alanine aminotransferase 56 Prolapse 56 Subarachnoid hemorrhage 56 Radiation Exposure 56 primary hyperparathyroidism 56 Host Disease GvHD 56 asymptomatic bacteriuria 56 pancreatic adenocarcinoma 56 leiomyoma 56 Kidney Transplants 56 Data Suggest 56 hepatocellular carcinomas 56 Anaplastic 56 recurrent VTE 56 Gastric Bypass Surgery 56 obstructive coronary 56 Astrocytoma 56 Adjuvant chemotherapy 56 cutaneous squamous cell carcinoma 56 Treatment Regimen 56 Hepatic 56 Premature Death 56 serum aminotransferase levels 56 myeloproliferative disorder 56 Respiratory Syncytial Virus 56 mycosis fungoides 56 Anaemia 56 hyperalgesia 56 postoperative AF 56 neoplasia 56 Cancer Cells 56 Statin Use 56 Aortic Valve 56 Breast Cancer Survival 56 elevated LDH 56 Cardiovascular Risk 56 hepatic cirrhosis 56 glomerular filtration 56 reinfarction 56 Circulating tumor cells 56 MGUS 56 arteriography 56 Estrogen Receptor 56 Clostridium difficile Infection 56 invasive candidiasis 56 Secondary Hyperparathyroidism 56 lymph node involvement 56 Cancer Incidence Mortality 56 Endocarditis 56 Peripheral Blood 56 Chronic Lymphocytic Leukemia 56 acute rheumatic fever 56 Staph Infection 56 Stable Coronary Artery 56 Vertebral Fractures 56 completely resected 56 hyperacute 56 Randomized Phase II 56 RECIST Response Evaluation Criteria 56 Muscle Function 56 Prehypertension 56 Lumpectomy 56 Respiratory Illness 56 resistant hormone refractory 56 extramedullary 56 renal tumors 56 Ectopic Pregnancy 56 Hormonal Therapy 56 Histologic 56 Generalized Anxiety Disorder 56 leukocyte counts 56 Trastuzumab 56 BERKELEY CA UroToday.com 56 Pleural Mesothelioma 56 malignant neoplasms 56 pyrexia mucositis sepsis febrile 56 prospective multicenter study 56 Cognitive Deficits 56 metaplasia 56 bronchogenic carcinoma 56 Epithelial Cell 56 Treatment Outcome 56 Dose Escalation 56 Events MACE 56 revascularisation 56 Vitamin D Deficiency 56 Beta Blockers 56 cervical intraepithelial neoplasia 56 Tumor Suppressor Gene 56 Mucositis 56 Chronic Myelogenous Leukemia 56 haematuria 56 Irregular Heartbeat 55 Pegylated Interferon 55 Genetic Variant 55 Aromatase Inhibitors 55 Hyperglycemia 55 Neoplasia 55 Genetic Disorder 55 Combination Therapy 55 Kidney Injury 55 Periodontitis 55 Critical Limb Ischemia CLI 55 ACE Inhibitors 55 Genetic Variation 55 Prospective Randomized 55 Myocarditis 55 elevated ALT 55 Protein Linked 55 Peginterferon 55 abdominal adiposity 55 Colon Cancers 55 nodal metastasis 55 Controlled Study 55 Contrast Enhanced 55 Otitis Media 55 malignant lymphoma 55 gonococcal infection 55 troponin T 55 Kaplan Meier estimates 55 Idiopathic Pulmonary Fibrosis